General Information of Drug (ID: DMFU9VH)

Drug Name
GR-113808 Drug Info
Synonyms CHEMBL518682; GTPL259; [3H]GR 113808; GR 125487 [H3]; [1-[2-(methanesulfonamido)ethyl]piperidin-4-yl]methyl 1-(tritritiomethyl)indole-3-carboxylate
Cross-matching ID
PubChem CID
119376
ChEBI ID
CHEMBL73380
CAS Number
CAS 144625-51-4
TTD Drug ID
D08JLW

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Viral protein interaction with cytokine and cytokine re... 2.02 9.71e-3 84/100 (84%) CXCL10;CXCL9;CCL4;...
DNA replication 2.01 4.85e-3 34/36 (94.44%) MCM3;MCM5;POLE2;...
Allograft rejection 1.93 9.71e-3 32/38 (84.21%) PRF1;GZMB;HLA-DQA1;...
African trypanosomiasis 1.93 7.28e-3 32/37 (86.49%) IDO1;IL18;LAMA4;...
Asthma 1.90 9.71e-3 25/31 (80.65%) HLA-DQA1;HLA-DPB1;TNF;...
Systemic lupus erythematosus 1.88 1.46e-2 45/135 (33.33%) C1QA;C1QB;HLA-DQA1;...
Autoimmune thyroid disease 1.84 1.80e-2 46/53 (86.79%) PRF1;GZMB;HLA-DQA1;...
Cytosolic DNA-sensing pathway 1.81 2.06e-2 52/63 (82.54%) CXCL10;CCL4;AIM2;...
Graft-versus-host disease 1.80 1.83e-2 32/42 (76.19%) PRF1;GZMB;HLA-DQA1;...
Protein processing in endoplasmic reticulum -1.79 2.91e-2 127/171 (74.27%) ATF4;CRYAA;EDEM3;...
Ferroptosis -1.94 6.15e-3 36/41 (87.8%) TFRC;GSS;PCBP1;...
Lysosome -1.96 7.69e-3 115/128 (89.84%) PPT2;HEXA;SMPD1;...
Protein export -1.98 1.03e-2 17/23 (73.91%) SPCS3;SRPRB;SEC61A1;...
Nicotinate and nicotinamide metabolism -2.03 5.13e-3 25/35 (71.43%) BST1;SIRT5;NADSYN1;...
Mineral absorption -2.05 1.03e-2 48/60 (80%) ATP1A1;MT1HL1;MT1F;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H